PhaseBio Pharmaceuticals Inc·4

Sep 10, 4:10 PM ET

Mow Jonathan P 4

4 · PhaseBio Pharmaceuticals Inc · Filed Sep 10, 2019

Insider Transaction Report

Form 4
Period: 2019-09-06
Mow Jonathan P
DirectorChief Executive Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2019-09-06$1.24/sh+19,000$23,560109,243 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2019-09-0619,000158,767 total
    Exercise: $1.24From: 2018-10-08Exp: 2024-11-04Common Stock (19,000 underlying)

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION